ArticleCancer causes & control : CCC2023
The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review.
Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.
- Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.Nature communications · 2026Pooled it
- Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.Journal of surgical oncology · 2025Pooled it
- Enhancement of Patient-Centered Lung Cancer Screening: The MyLungHealth Randomized Clinical Trial.JAMA oncology · 2026Trial
- Mobile Intervention for Increasing COVID-19 Testing in K-12 Schools Serving Disadvantaged Communities: Randomized Controlled Trial of SCALE-UP Counts.Journal of medical Internet research · 2025Trial
- Fatigue, physical function, and the context of social vulnerability for older adults with cancer.Journal of geriatric oncology · 2025Trial
- Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024Trial
- Cancer Screening Behaviors among People with HIV in the United States and the Role of Multi-Level Social and Economic Factors: A Systematic Review.Current epidemiology reports · 2026Article
- Article
- Medical Debt and Advanced Cancer Stage at Diagnosis.JAMA network open · 2026Article
- Geographic access to triple negative breast cancer clinical trials: are trials located near patients?Breast cancer research and treatment · 2026Article
- Unequal paths to care: a scoping review of access and cancer outcomes in Alabama.Journal of cancer survivorship : research and practice · 2026Review
- Preliminary development of a Risk Factor Index to identify older adults at risk of adverse medication-related outcomes: A Delphi Study.Exploratory research in clinical and social pharmacy · 2026Article
- Differences in Community Recognition of Autism Between Special Education and Clinicians: Insights From Public Health Surveillance in Arizona.Journal of autism and developmental disorders · 2026Article
- Associations Between Community Social Vulnerability or Socioeconomic Deprivation and Respiratory Virus Infection in Decedents in a Large, Urban Medical Examiner's Office.Journal of racial and ethnic health disparities · 2026Article
- Social vulnerability and survival among patients with high-grade glioma treated at a tertiary cancer center.Journal of neuro-oncology · 2026Article
- Social determinants as pathways in disparities in oral cavity cancer stage at diagnosis: a registry-based analysis from 2010-2020.Cancer causes & control : CCC · 2026Article
- Associations Between Neighborhood Social Vulnerability and the Distribution of Rhinologists in the United States.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026Article
- Substance use treatment and overdose patterns in high and low social vulnerability counties: a trends analysis in New Jersey from 2014-2022.Addictive behaviors reports · 2026Article
- Blood Pressure Control and Mortality Among US Veterans.Hypertension (Dallas, Tex. : 1979) · 2026Article
- Barriers to Adhering to Post-operative Recovery in Spinal Decompression Surgery and Impact on Patient-Reported Outcomes.Global spine journal · 2026Article
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe social vulnerability index (SVI), developed by the Centers for Disease Control and Prevention, is a novel composite measure encompassing multiple variables that correspond to key social determinants of health. The objective of this review was to investigate innovative applications of the SVI to oncology research and to employ the framework of the cancer care continuum to elucidate further research opportunities.
methodsA systematic search for relevant articles was performed in five databases from inception to 13 May 2022. Included studies applied the SVI to analyze outcomes in cancer patients. Study characteristics, patent populations, data sources, and outcomes were extracted from each article. This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
resultsIn total, 31 studies were included. Along the cancer care continuum, five applied the SVI to examine geographic disparities in potentially cancer-causing exposures; seven in cancer diagnosis; fourteen in cancer treatment; nine in treatment recovery; one in survivorship care; and two in end-of-life care. Fifteen examined disparities in mortality.
conclusionIn highlighting place-based disparities in patient outcomes, the SVI represents a promising tool for future oncology research. As a reliable geocoded dataset, the SVI may inform the development and implementation of targeted interventions to prevent cancer morbidity and mortality at the neighborhood level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.